Skip to search formSkip to main contentSkip to account menu

tigemonam

Known as: Acetic acid, (((1-(2-amino-4-thiazolyl)-2-((2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl)amino)-2-oxoethylidene)amino)oxy)-, (S-(Z))- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
Oral and parenteral administration of aztreonam and oral administration of tigemonam to conventional mice caused a decrease in… 
1989
1989
The activity of tigemonam was compared with that of aztreonam, cefuroxime, cephalexin, amoxicillin/clavulanate potassium… 
1989
1989
Tigemonam, a new oral monobactam, was at least as active as aztreonam or carumonam against clinical isolates of… 
1988
1988
Tigemonam is an orally administered monobactam. At less than or equal to 1 microgram/ml it inhibited the majority of strains of… 
1988
1988
The discovery of the monobactams led to the successful development of aztreonam as the first of this novel class of beta‐lactam… 
1988
1988
At five geographically separate medical centers, over 6,000 clinical bacterial isolates were tested for their susceptibility to… 
1988
1988
The in-vitro activity against Gram-negative aerobic bacterial pathogens of a new oral monobactam, tigemonam, was compared with… 
1987
1987
Tigemonam, a novel, orally administered monobactam, exhibited potent and specific activity in vitro against members of the family… 
1987
1987
Tigemonam, a new monobactam with excellent activity against gram-negative bacteria, was evaluated for in vivo efficacy and…